33Z-19077-24709 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-13
Dose 1 — Moderna
2022-08-10
Dose 2 — Moderna
2022-10-05
Registered in v-safe
2022-11-11
Health check-in — 3 months, dose 2, dependent
Feeling: Good

Adult check-in
2023-02-10
Survey response — 6 months, dose 2, dependent
MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-02-10
Report sent to call center — 6 months, dose 2, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-02-13
Call successful
Does not wish to fill out VAERS report

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-13	Moderna	No
2	2022-08-10	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2023-02-10	Successful 2023-02-13	Does not wish to fill out VAERS report

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release